Return to News/Press Releases Page
![]() |
50 Cobham Dr |
|
June 20th, 2008
Minrad recently submitted a supplemental new drug application to the Food & Drug Administration to provide for the extension of the expiration date of Sojourn™ Sevoflurane to three years. The FDA has approved MINRAD’s application.